PAPER Leuchter AF, Newton TF, Cook IA, Walter DO, Rosenberg-Thompson S, Lachenbruch PA

Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia.

Brain. 1992 Oct;115 ( Pt 5):1543-61. PubMed: 1422803

PAPER Cook IA, Leuchter AF

Synaptic dysfunction in Alzheimer's disease: clinical assessment using quantitative EEG.

Behav Brain Res. 1996 Jun;78(1):15-23. PubMed: 8793033

PAPER Leuchter AF, Cook IA, Hunter AM, Cai C, Horvath S

Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression.

PLoS One. 2012;7(2):e32508. PubMed: 22384265

PAPER , Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA

An integrated map of genetic variation from 1,092 human genomes.

Nature. 2012 Nov 1;491(7422):56-65. PubMed: 23128226

Biomarker Progress? Picking the New, Better Measuring the Old

RESEARCH NEWS 2012-11-15 Research News Even as Alzheimer’s disease biomarkers are wending their way through a lengthy standardization and qualification process, individual labs are experimenting with deploying them toward the next challenge, that is, to improve the differential d

CTAD: EEG Gains Luster as More Trials Incorporate Biomarkers

CONFERENCE COVERAGE 2012-11-15 Conference Coverage The 5th Clinical Trials in Alzheimer’s Disease conference, held 29-31 October in Monaco, showcased the field’s pressing need for biomarkers as outcome measures. Several talks focused on electroencephalography (EEG), a somewhat overlook

Contest Winners Offer Solutions for Tracking ALS

RESEARCH NEWS 2012-11-15 Research News The nonprofit Prize4Life announced yesterday that it would reward two scientific teams $20,000 each for their proposed solutions to track the progression of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that causes muscle

PAPER Mendonça DM, Pizzati L, Mostacada K, de S Martins SC, Higashi R, Ayres Sá L, Moura Neto V, Chimelli L, Martinez AM

Neuroproteomics: an insight into ALS.

Neurol Res. 2012 Dec;34(10):937-43. PubMed: 23146297

PAPER Noelker C, Stuckenholz V, Reese JP, Alvarez-Fischer D, Sankowski R, Rausch T, Oertel WH, Hartmann A, van Patten S, Al-Abed Y, Bacher M

CNI-1493 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in the Acute MPTP Mouse Model of Parkinson's Disease.

Neurodegener Dis. 2012 Nov 7; PubMed: 23147695

PAPER Baranowska-Bosiacka I, Strużyńska L, Gutowska I, Machalińska A, Kolasa A, Kłos P, Czapski GA, Kurzawski M, Prokopowicz A, Marchlewicz M, Safranow K, Machaliński B, Wiszniewska B, Chlubek D

Perinatal exposure to lead induces morphological, ultrastructural and molecular alterations in the hippocampus.

Toxicology. 2013 Jan 7;303C:187-200. PubMed: 23146751

PAPER Iłzecka J

Serum soluble OX40 in patients with amyotrophic lateral sclerosis.

Acta Clin Croat. 2012 Mar;51(1):3-7. PubMed: 22919996

Dorothy Wills

Genetic Interest
Delta, Canada

PAPER Willis GL, Moore C, Armstrong SM

Breaking away from dopamine deficiency: an essential new direction for Parkinson's disease.

Rev Neurosci. 2012;23(4):403-28. PubMed: 23089606

PAPER Aronin N, Moore M

Hunting down huntingtin.

N Engl J Med. 2012 Nov;367(18):1753-4. PubMed: 23113488

PAPER Malpass K

Neurodegenerative disease: neural stem cell degeneration in PD linked to nuclear defects.

Nat Rev Neurol. 2012 Dec;8(12):660. PubMed: 23147848